![]() |
| Site Navigation | Chemotherapy - Mustargen |
|
|
|
| Mustargen (generic name mechlorethamine,
MSD, mustine or nitrogen mustard) is a chemotherapy agent used in the treatment of Hodgkin's
Lymphoma / Disease and some forms of Non-Hodgkin's Lymphoma. It usually comes in liquid
form which is given by vein in multiple chemotherapy but for skin lymphomas
it may be mixed into a topical cream. It is more often than not used in conjunction with other
chemotherapy agents in a multidrug regimen. The drug acts as an alkylating agent. The
development of this drug stems from the use of mustard compounds during World War I. Before taking this medicine: Inform your doctor or pharmacist of all prescription and over-the-counter medicines you take. Inform your medical doctor of any other medical conditions or allergies or if you are pregnant or breast feeding. Dosing:
For IV, this drug is usually administered by IV in a medical facility.
Exact dosage is determined by a doctor and is based on body size.
For topical cream, consult with your doctors on administration. Common: this drug is very irritating to the veins. During
IV administration tell your chemotherapy administrator if burning or pain develops -
they may be able to slow down the infusion or dilute the drug. After the chemotherapy
session, you may want to use warm wet compresses at the injection site. Some of the regimens using mustargen:
Mustargen Reference Links:
Manufacturer
Disclaimer: This information is general in nature. Please consult with a doctor or the literature provided with the drug packaging if you need specific information on a drug. The author is not responsible for missing or inaccurate information and the reader assumes full responsibility for their actions. As always, please consult with medical personnel before undertaking any medical treatment. For more information on Hodgkin's Disease, please see the following pages: :
The Main Page - gateway to support and more This page is a work in progress - if you have more complete information, references, or other information please contact the author. The author is not in the medical field and does not warrant the correctness of the material on this page or the sites linked - please take online information and consult with your own medical team to make informed decisions. Copyright © 1998-2006 Lymphoma
Information Network - All
Rights Reserved |
||